Zobrazeno 1 - 10
of 220
pro vyhledávání: '"JR Barrett"'
Autor:
JR Barrett, SE Silk, CG Mkindi, KM Kwiatkowska, MM Hou, AM Lias, WF Kalinga, IM Mtaka, K McHugh, M Bardelli, H Davies, LDW King, NJ Edwards, VS Chauhan, P Mukherji, S Rwezaula, CE Chitnis, AI Olotu, AM Minassian, SJ Draper, CM Nielsen
We have previously reported primary endpoints of a clinical trial testing two vaccine platforms for delivery ofPlasmodium vivaxmalaria DBPRII: viral vectors (ChAd63, MVA) and protein/adjuvant (PvDBPII with 50µg Matrix-M™ adjuvant). Delayed boostin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::107f1e6152327a535d28955d719dbbf8
https://doi.org/10.1101/2023.03.17.23287040
https://doi.org/10.1101/2023.03.17.23287040
Autor:
CM Nielsen, JR Barrett, C Davis, JK Fallon, C Goh, AR Michell, C Griffin, A Kwok, C Loos, S Darko, F Laboune, SE Silk, M Tekman, JR Francica, A Ransier, RO Payne, AM Minassian, DA Lauffenburger, RA Seder, DC Douek, G Alter, SJ Draper
BackgroundAntibodies are crucial for vaccine-mediated protection against many pathogens. Modifications to vaccine delivery that increase antibody magnitude, longevity, and/or quality are therefore of great interest for maximising efficacy. We have pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9a60013b7e0eb077043ca1e931ecf7a
https://doi.org/10.1101/2022.04.25.22274161
https://doi.org/10.1101/2022.04.25.22274161
Autor:
Potter Jr., Barrett G., Simmons-Potter, Kelly, Warren, W. L., Ruffner, Judith A., Meister, Dorothy C.
Publikováno v:
Proceedings of SPIE; Nov1997, Issue 1, p146-153, 8p
Publikováno v:
Proceedings of SPIE; Nov1997, Issue 1, p93-99, 7p
Publikováno v:
Journal of the American Ceramic Society; Apr2010, Vol. 93 Issue 4, p1089-1095, 7p, 1 Diagram, 1 Chart, 5 Graphs
Publikováno v:
Applied Physics Letters; 4/1/1996, Vol. 68 Issue 14, p2011, 3p, 3 Graphs
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Silk SE; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Kalinga WF; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Salkeld J; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Mtaka IM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Ahmed S; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Milando F; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Diouf A; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Bundi CK; Kenya Medical Research Institute (KEMRI) Centre for Geographic Medicine, KEMRI-Wellcome Trust Research Programme and Accredited Research Centre, Open University, Kilifi, Kenya., Balige N; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Hassan O; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mkindi CG; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Rwezaula S; Muhimbili National Hospital, Dar es Salaam, Tanzania., Athumani T; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mswata S; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Lilolime NS; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Simon B; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Msami H; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mohamed M; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., David DM; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mohammed L; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Nyaulingo G; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mwalimu B; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Juma O; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mwamlima TG; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Sasamalo IA; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Mkumbange RP; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Kamage JJ; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Barrett JR; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., King LDW; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Hou MM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Pulido D; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Oxford, UK., Carnrot C; Novavax AB, Uppsala, Sweden., Lawrie AM; Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Oxford, UK., Cowan RE; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Nugent FL; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Roberts R; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Cho JS; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Nielsen CM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Draper SJ; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Olotu AI; Interventions and Clinical Trials Department, Ifakara Health Institute, Bagamoyo, Tanzania., Minassian AM; Department of Biochemistry and Kavli Institute for Nanoscience Discovery and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. Electronic address: angela.minassian@bioch.ox.ac.uk.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Oct; Vol. 24 (10), pp. 1105-1117. Date of Electronic Publication: 2024 Jun 13.
Autor:
Dookie RS; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Villegas-Mendez A; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Cheeseman A; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Jones AP; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Barroso R; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Barrett JR; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Draper SJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Janse CJ; Leiden Malaria Group, Center of Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, The Netherlands., Grogan JL; Department of Cancer Immunology, Genentech, South San Francisco, California, USA., MacDonald AS; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Couper KN; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Publikováno v:
Infection and immunity [Infect Immun] 2024 Sep 26, pp. e0034524. Date of Electronic Publication: 2024 Sep 26.